GUIDANCES FOR THE CASE OF MEDICINES CAN BE RECALLED
On March 04, 2018, the Ministry of Health issues the Circular No. 11/2018/TT-BYT on drug/drug ingredient quality.
Accordingly, The drug trader/user must discontinue provision and use of the recalled drugs; place inventory drugs in quarantine; make a list of drug traders/users and individuals (if any) that purchased those drugs, contact them and receive the returned drugs; return the drugs to the providers;
The manufacturer (of domestic drugs) and importer cooperate with the import entrustor or distribution hub (of imported drugs) in recalling unconformable drugs.
The drug trader/provider that fails to recall drugs or receiving returned drugs shall be notified by facilities and individuals purchasing those drugs to the local Department of Health and face actions.
This Circular takes effect on June 20, 2018.
